Trial Profile
A Multicenter, Open Label Study to Evaluate Safety and Efficacy of Posaconazole Oral Suspension in Treatment of Invasive Fungal Infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 12 Mar 2015 New trial record